Andrew W. Zarker, MD

McGovern Medical School at UTHealth

Poster(s):

• P2692 - Combination Vedolizumab and Ustekinumab for Refractory Crohn’s Disease After Immune Checkpoint Inhibitors
  Monday, October 28, 2024

  10:30 AM – 4:00 PM ET